Patent Number: 6,168,793

Title: Heat shock protein 70 preparations in vaccination against cancer and infectious disease

Abstract: The present invention relates to compositions comprising a population of non-covalent heat shock protein 70-peptide complexes purified from mammalian tumor tissues or mammalian cells infected with an infectious agent. When administered to a mammal, the compositions are capable of eliciting an immune response. The compositions are also useful for treatment of cancer and infectious diseases in animals.

Inventors: Srivastava; Pramod K. (New York, NY)

Assignee: Mount Sinai School of Medicine of New York University

International Classification: A61K 39/00 (20060101); C07K 14/435 (20060101); C07K 14/47 (20060101); A61K 38/00 (20060101); A61R 039/385 (); A01N 037/18 (); A61K 038/02 (); A23J 001/00 ()

Expiration Date: 01/02/2018